SCHEMBL4635557

SCHEMBL4635557

CCN(CC)C1CCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3560285 0.93 NOS3 (0.35)
SCHEMBL4720623 0.87
SCHEMBL4765143 0.84
SCHEMBL4720127 0.82 ADH1A (0.31)
SCHEMBL4724577 0.81 ADH1A (0.32)
SCHEMBL4723746 0.79
SCHEMBL4722510 0.79 CYP1A2 (0.30)
SCHEMBL4721340 0.78 CYP1A2 (0.31)
SCHEMBL4722799 0.76 ADH1A (0.34)
SCHEMBL4724006 0.76 DRD2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1931645-A2 N- (3-AMINO-QUINOXALIN-2-YL) -SULFONAMIDE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS Exelixis, Inc. (US) 2008-06-18 EP disclosed
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 WO disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2007044729-A2 N- (3-AMINO-QUINOXALIN-2-YL) -SULFONAMIDE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS EXELIXIS, INC. (US) 2007-04-19 WO disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed
US-20060205697-A1 Novel betulin derivatives, preparation thereof and use thereof MYREXIS, INC. 2006-09-14 US disclosed
US-20050161184-A1 Amphoteric and cationic fluorescent whitening agents CIBA SPECIALTY CHEMICALS CORP. 2005-07-28 US disclosed
EP-1485361-A1 AMPHOTERIC AND CATIONIC FLUORESCENT WHITENING AGENTS Ciba SC Holding AG (CH) 2004-12-15 EP disclosed
WO-2003078406-A1 AMPHOTERIC AND CATIONIC FLUORESCENT WHITENING AGENTS CIBA SPECIALTY CHEMICALS HOLDING INC. (US) 2003-09-25 WO disclosed
US-5250735-A Antitumor or antiinflammatory agents, analgesics UNIVERSITY OF PITTSBURGH (US) 1993-10-05 US disclosed